SLXP

SALIX PHARMACEUTICALS LTD DEL
SLXP

Delisted

SLXP was delisted on the 31st of March, 2015.

304 hedge funds and large institutions have $6.82B invested in SALIX PHARMACEUTICALS LTD DEL in 2014 Q1 according to their latest regulatory filings, with 78 funds opening new positions, 110 increasing their positions, 98 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

12% more repeat investments, than reductions

Existing positions increased: 110 | Existing positions reduced: 98

8% more capital invested

Capital invested by funds: $6.3B → $6.82B (+$520M)

Holders
304
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$81.1M
Puts
$29.7M
Net Calls
Net Calls Change

Top Buyers

1 +$161M
2 +$75.1M
3 +$59.9M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$55.9M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$36.4M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$814M
2
$733M
3
$427M
4
$269M
5
$238M
6
$197M
7
$195M
8
$183M
9
$176M
10
$173M
11
$161M
12
$148M
13
$120M
14
$116M
15
$112M
16
$107M
17
$105M
18
$78M
19
$75.4M
20
$67.3M
21
$65.4M
22
$61.9M
23
$60.1M
24
$53.6M
25
$52.4M